PHASE III RANDOMIZED STUDY OF ENZASTAURIN/R-CHOP VS PLACEBO/R-CHOP IN FRONTLINE HIGH RISK DIFFUSE LARGE B CELL LYMPHOMA PATIENTS WITH GENOMIC BIOMARKER DGM1 (ENGINE STUDY)

Autor:	Lifu Zhang, Yu-Hsuan Liu, Jun Zhu, Stephen D. Smith, G.S. Nowakowski, Yuqin Song, Manoj A. Jivani, Ronald Shazer, Isabel Han, Owen A. O'Connor, Wen Luo
Rok vydání:	2019
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Hematology General Medicine medicine.disease Placebo law.invention Genomic Biomarker chemistry.chemical_compound Enzastaurin chemistry Randomized controlled trial law Internal medicine medicine business Diffuse large B-cell lymphoma
Zdroj:	Hematological Oncology. 37:70-70
ISSN:	0278-0232
DOI:	10.1002/hon.37_2629
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e17371f0bcbfb5442586149e11e6e6af https://doi.org/10.1002/hon.37_2629 Zobrazit plný text záznamu Plný text